Placebo
LX9211.1-202-PHN
Phase 2 small_molecule completed
Quick answer
Placebo for Postherpetic Neuralgia is a Phase 2 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Postherpetic Neuralgia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed